Ariela Rivkah Orkaby, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 19 | 2024 | 2519 | 4.830 |
Why?
|
Frail Elderly | 18 | 2024 | 693 | 2.620 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 12 | 2024 | 3255 | 2.530 |
Why?
|
Yoga | 3 | 2023 | 253 | 2.150 |
Why?
|
Geriatric Assessment | 14 | 2024 | 1372 | 1.780 |
Why?
|
Cardiovascular Diseases | 17 | 2024 | 15165 | 1.640 |
Why?
|
Nails | 3 | 2021 | 292 | 1.290 |
Why?
|
Geriatrics | 5 | 2021 | 396 | 1.020 |
Why?
|
Aged | 73 | 2024 | 163280 | 1.000 |
Why?
|
Dementia | 5 | 2024 | 2518 | 0.960 |
Why?
|
Primary Prevention | 4 | 2021 | 1167 | 0.960 |
Why?
|
Stroke | 7 | 2023 | 9981 | 0.850 |
Why?
|
Atherosclerosis | 3 | 2023 | 3445 | 0.830 |
Why?
|
Terminology as Topic | 3 | 2019 | 1547 | 0.830 |
Why?
|
Meditation | 1 | 2023 | 242 | 0.750 |
Why?
|
Postural Balance | 2 | 2021 | 620 | 0.720 |
Why?
|
Tai Ji | 1 | 2023 | 285 | 0.710 |
Why?
|
Myocardial Infarction | 7 | 2023 | 11727 | 0.670 |
Why?
|
Task Performance and Analysis | 1 | 2023 | 780 | 0.650 |
Why?
|
Hospitals, Veterans | 1 | 2021 | 404 | 0.650 |
Why?
|
Mobility Limitation | 1 | 2021 | 409 | 0.600 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2023 | 980 | 0.590 |
Why?
|
Independent Living | 2 | 2019 | 568 | 0.590 |
Why?
|
International Classification of Diseases | 2 | 2021 | 867 | 0.560 |
Why?
|
Pravastatin | 1 | 2018 | 395 | 0.560 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 204 | 0.550 |
Why?
|
Humans | 90 | 2024 | 744343 | 0.530 |
Why?
|
Cholesterol | 4 | 2023 | 2917 | 0.520 |
Why?
|
Heart Arrest | 2 | 2023 | 1470 | 0.510 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 882 | 0.490 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 2282 | 0.490 |
Why?
|
Accidental Falls | 2 | 2021 | 1062 | 0.490 |
Why?
|
Atrial Fibrillation | 4 | 2024 | 5034 | 0.480 |
Why?
|
Executive Function | 1 | 2023 | 1364 | 0.470 |
Why?
|
Carotid Stenosis | 1 | 2021 | 854 | 0.470 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1677 | 0.460 |
Why?
|
Physicians | 2 | 2022 | 4567 | 0.460 |
Why?
|
Aged, 80 and over | 24 | 2023 | 57776 | 0.450 |
Why?
|
Mortality | 3 | 2021 | 2864 | 0.450 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1344 | 0.440 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2208 | 0.430 |
Why?
|
Male | 46 | 2024 | 350118 | 0.430 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1405 | 0.430 |
Why?
|
Health Status Indicators | 1 | 2018 | 969 | 0.430 |
Why?
|
Aspirin | 2 | 2022 | 3282 | 0.420 |
Why?
|
Risk Adjustment | 1 | 2016 | 594 | 0.410 |
Why?
|
Heart Failure | 7 | 2023 | 10900 | 0.390 |
Why?
|
Anticholesteremic Agents | 1 | 2018 | 979 | 0.390 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.380 |
Why?
|
Metformin | 1 | 2017 | 835 | 0.370 |
Why?
|
Physical Examination | 3 | 2023 | 1237 | 0.370 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1411 | 0.370 |
Why?
|
Coronary Disease | 3 | 2023 | 6077 | 0.360 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1076 | 0.360 |
Why?
|
Research | 1 | 2019 | 1999 | 0.360 |
Why?
|
Cardiology | 1 | 2021 | 1668 | 0.350 |
Why?
|
Life Style | 2 | 2018 | 3835 | 0.340 |
Why?
|
Female | 39 | 2024 | 380194 | 0.340 |
Why?
|
Exercise | 3 | 2023 | 5615 | 0.340 |
Why?
|
Retrospective Studies | 15 | 2023 | 77449 | 0.330 |
Why?
|
Aging | 4 | 2023 | 8664 | 0.320 |
Why?
|
Risk Assessment | 8 | 2023 | 23338 | 0.320 |
Why?
|
Warfarin | 1 | 2016 | 1496 | 0.320 |
Why?
|
Memory | 1 | 2018 | 2174 | 0.310 |
Why?
|
United States | 19 | 2024 | 69872 | 0.310 |
Why?
|
Risk Factors | 17 | 2023 | 72290 | 0.310 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2021 | 9959 | 0.290 |
Why?
|
Preoperative Care | 1 | 2016 | 2250 | 0.290 |
Why?
|
Prosthesis-Related Infections | 1 | 2012 | 538 | 0.280 |
Why?
|
Vitamin D | 1 | 2019 | 3223 | 0.270 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 2872 | 0.260 |
Why?
|
Stroke Volume | 5 | 2023 | 5007 | 0.240 |
Why?
|
United States Department of Veterans Affairs | 4 | 2021 | 875 | 0.240 |
Why?
|
Life Expectancy | 3 | 2021 | 1184 | 0.230 |
Why?
|
Proportional Hazards Models | 5 | 2019 | 12354 | 0.230 |
Why?
|
Institutionalization | 1 | 2023 | 104 | 0.220 |
Why?
|
Trail Making Test | 1 | 2023 | 57 | 0.220 |
Why?
|
Sodium | 2 | 2019 | 1623 | 0.220 |
Why?
|
Anticoagulants | 2 | 2021 | 4599 | 0.220 |
Why?
|
England | 1 | 2024 | 522 | 0.210 |
Why?
|
State Medicine | 1 | 2024 | 217 | 0.210 |
Why?
|
Dementia, Vascular | 1 | 2023 | 128 | 0.210 |
Why?
|
Prospective Studies | 9 | 2023 | 53288 | 0.210 |
Why?
|
Propensity Score | 2 | 2020 | 1781 | 0.200 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2012 | 1462 | 0.200 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3537 | 0.190 |
Why?
|
Time Factors | 7 | 2021 | 40075 | 0.190 |
Why?
|
Pituitary-Adrenal System | 1 | 2023 | 553 | 0.180 |
Why?
|
Adult Children | 1 | 2020 | 100 | 0.180 |
Why?
|
Middle Aged | 17 | 2023 | 213383 | 0.180 |
Why?
|
Hand Strength | 1 | 2023 | 448 | 0.180 |
Why?
|
Skilled Nursing Facilities | 1 | 2024 | 372 | 0.180 |
Why?
|
Ventricular Function, Left | 4 | 2023 | 3670 | 0.180 |
Why?
|
Cohort Studies | 8 | 2023 | 40561 | 0.180 |
Why?
|
Teaching Rounds | 1 | 2023 | 253 | 0.170 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2023 | 703 | 0.170 |
Why?
|
Health Status | 3 | 2021 | 4034 | 0.170 |
Why?
|
Age Factors | 4 | 2020 | 18370 | 0.170 |
Why?
|
Feasibility Studies | 3 | 2023 | 5078 | 0.170 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 1965 | 0.170 |
Why?
|
Rehabilitation Centers | 1 | 2020 | 254 | 0.170 |
Why?
|
Coronary Artery Bypass | 3 | 2023 | 2289 | 0.170 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.160 |
Why?
|
Veterans Health | 1 | 2020 | 216 | 0.160 |
Why?
|
Internship and Residency | 1 | 2018 | 5788 | 0.160 |
Why?
|
Dietary Supplements | 2 | 2022 | 3297 | 0.160 |
Why?
|
Acetaminophen | 1 | 2022 | 545 | 0.160 |
Why?
|
Interleukin-1beta | 1 | 2023 | 972 | 0.160 |
Why?
|
Rehabilitation | 1 | 2019 | 134 | 0.150 |
Why?
|
Hospital Mortality | 2 | 2022 | 5317 | 0.150 |
Why?
|
Cholecalciferol | 1 | 2022 | 537 | 0.150 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13989 | 0.150 |
Why?
|
Comorbidity | 3 | 2023 | 10388 | 0.150 |
Why?
|
Health Services for the Aged | 1 | 2019 | 269 | 0.140 |
Why?
|
Foot | 1 | 2020 | 527 | 0.140 |
Why?
|
Nursing Homes | 1 | 2024 | 1036 | 0.140 |
Why?
|
Cognition | 3 | 2024 | 6770 | 0.140 |
Why?
|
Medicare | 5 | 2024 | 6566 | 0.130 |
Why?
|
Electronic Health Records | 2 | 2024 | 4468 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 933 | 0.120 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2418 | 0.120 |
Why?
|
Vitamins | 1 | 2022 | 1622 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1790 | 0.120 |
Why?
|
Mentors | 1 | 2018 | 631 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 11725 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5751 | 0.110 |
Why?
|
Cause of Death | 2 | 2022 | 3584 | 0.110 |
Why?
|
Data Mining | 1 | 2018 | 537 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2023 | 63114 | 0.110 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 840 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 700 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 850 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 950 | 0.110 |
Why?
|
Hyperlipidemias | 1 | 2018 | 789 | 0.110 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.110 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 753 | 0.110 |
Why?
|
Yogurt | 1 | 2012 | 72 | 0.110 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6487 | 0.100 |
Why?
|
Overweight | 1 | 2023 | 2371 | 0.100 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 401 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2017 | 2971 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2020 | 1475 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2073 | 0.100 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1536 | 0.100 |
Why?
|
General Surgery | 1 | 2022 | 1636 | 0.090 |
Why?
|
Self Report | 1 | 2022 | 3558 | 0.090 |
Why?
|
Hospitalization | 4 | 2022 | 10262 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1440 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2023 | 3864 | 0.090 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.080 |
Why?
|
Loneliness | 1 | 2011 | 185 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2020 | 15295 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10397 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3610 | 0.070 |
Why?
|
Quality of Life | 2 | 2021 | 12804 | 0.070 |
Why?
|
Registries | 1 | 2021 | 8089 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1439 | 0.070 |
Why?
|
Odds Ratio | 1 | 2017 | 9849 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3229 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3887 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12788 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25043 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 8987 | 0.060 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2023 | 17 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12959 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39050 | 0.050 |
Why?
|
Adult | 5 | 2023 | 214055 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5137 | 0.050 |
Why?
|
Podiatry | 1 | 2020 | 22 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8642 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 29063 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 294 | 0.040 |
Why?
|
NAD | 1 | 2023 | 593 | 0.040 |
Why?
|
Patient Discharge | 2 | 2022 | 3313 | 0.040 |
Why?
|
Knowledge Bases | 1 | 2019 | 85 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 711 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8480 | 0.040 |
Why?
|
Body Weight | 2 | 2023 | 4669 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1814 | 0.040 |
Why?
|
Prevalence | 3 | 2021 | 15226 | 0.040 |
Why?
|
Absorbable Implants | 1 | 2019 | 342 | 0.040 |
Why?
|
Aftercare | 1 | 2022 | 866 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3158 | 0.030 |
Why?
|
Diuretics | 1 | 2018 | 592 | 0.030 |
Why?
|
Program Development | 1 | 2021 | 1316 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2170 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3913 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 19905 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5319 | 0.030 |
Why?
|
Polymers | 1 | 2019 | 1621 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1873 | 0.030 |
Why?
|
Sirolimus | 1 | 2019 | 1564 | 0.030 |
Why?
|
Aortic Valve | 1 | 2021 | 1922 | 0.030 |
Why?
|
Depression | 1 | 2011 | 7766 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 6993 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1041 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1573 | 0.020 |
Why?
|
Group Practice | 1 | 2011 | 149 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2021 | 4577 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3528 | 0.020 |
Why?
|
Observation | 1 | 2011 | 312 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20129 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14722 | 0.020 |
Why?
|
Primary Health Care | 1 | 2024 | 4558 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.020 |
Why?
|
Stents | 1 | 2019 | 3280 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9687 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8554 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12026 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5097 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5102 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 20947 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5102 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13284 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9146 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2023 | 25625 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7659 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 2682 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2684 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8663 | 0.010 |
Why?
|
Heart Diseases | 1 | 2011 | 2788 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8324 | 0.010 |
Why?
|
Pain | 1 | 2011 | 4986 | 0.010 |
Why?
|